Ft. Lauderdale, FL, December 2, 2016 – Clarity Genetics announced today that it brought its Clarity Informed Prenatal Test in-house.
“By bringing the test in house, we’ve been able to improve customer service through shortened turnaround times and at the same time keep costs down for patients,” says Alan Mack, CEO of Clarity Genetics.
A decrease in turnaround times by 25% combined with an increase in test volume has led to more job opportunities at the Grand Rapid headquarters.
The Clarity Informed Prenatal Test uses the illumina NGS platform and can, with the highest degree of accuracy, determine the presence of chromosomal aneuploidies in a developing fetus. The test can be done as early as 10 weeks into the pregnancy and has no limitations in terms of ethnicity, body mass index, assisted reproductive technology, or egg donor cases.
Patients can use the information this test provides to learn more about the risk of non-inherited chromosomal conditions and weigh the benefits and risks of further invasive diagnostic procedures.
About Clarity Genetics
Clarity Genetics LLC is a leading clinical molecular diagnostics laboratory delivering highly accurate and precise genetic screening to detect genetic diseases or abnormalities to help guide family planning decisions for couples and their healthcare providers. Unlike other laboratories, Clarity Genetics’ technology examines the entire gene rather than parts of the gene, giving families a comprehensive assessment of their true risk. Clarity Genetics is located in Fort Lauderdale, Florida.